US Stock MarketDetailed Quotes

NRXPW NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM)

Watchlist
  • 0.0836
  • +0.0036+4.50%
Close Jul 5 16:00 ET
0Market Cap0.00P/E (TTM)

NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-36.43%6M
-37.21%27.84M
-55.44%4.41M
-36.46%5.81M
-14.71%8.19M
-39.92%9.44M
-61.71%44.34M
-81.33%9.89M
-54.52%9.14M
-43.92%9.6M
Selling and administrative expenses
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
-63.56%27.31M
-88.33%5.43M
-63.74%5.01M
-46.68%6.64M
-General and administrative expense
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
-63.56%27.31M
-88.33%5.43M
-63.74%5.01M
-46.68%6.64M
Research and development costs
-52.11%1.75M
-21.47%13.37M
-43.13%2.53M
-19.74%3.31M
30.93%3.87M
-33.43%3.65M
-15.95%17.03M
-30.52%4.46M
-34.21%4.13M
-36.51%2.96M
Other operating expenses
----
--250K
--0
----
--250K
----
----
----
----
----
Operating profit
36.43%-6M
37.21%-27.84M
55.44%-4.41M
36.46%-5.81M
14.71%-8.19M
39.92%-9.44M
61.71%-44.34M
81.33%-9.89M
54.52%-9.14M
43.92%-9.6M
Net non-operating interest income expense
-230.13%-203K
50.20%374K
-104.51%-6K
-16.84%79K
530.43%145K
5,300.00%156K
1,483.33%249K
6,750.00%133K
2,000.00%95K
560.00%23K
Non-operating interest income
-82.69%27K
98.39%494K
-43.08%74K
25.26%119K
530.43%145K
--156K
--249K
--130K
--95K
--23K
Non-operating interest expense
--230K
--120K
2,766.67%80K
--40K
--0
--0
--0
-250.00%-3K
--0
--0
Other net income (expense)
81.42%-327K
-162.03%-2.69M
116.46%80K
-800.00%-333K
-125.97%-674K
-177.88%-1.76M
-80.96%4.33M
-102.15%-486K
99.78%-37K
-84.74%2.6M
Gain on sale of security
81.42%-327K
-974.80%-2.69M
116.46%80K
-800.00%-333K
-681.03%-674K
-1,221.02%-1.76M
-114.78%-250K
-155.93%-486K
99.78%-37K
-99.33%116K
Special income (charges)
----
--0
--0
--0
--0
----
-78.24%4.58M
--0
--0
798.31%2.48M
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
78.12%-4.58M
--0
--0
-798.31%-2.48M
Income before tax
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
Income tax
Net income
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
Net income continuous Operations
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
Minority interest income
Net income attributable to the parent company
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
Preferred stock dividends
Other preferred stock dividends
9K
0
Net income attributable to common stockholders
40.86%-6.53M
24.14%-30.16M
57.61%-4.34M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
88.61%-39.75M
66.32%-10.24M
75.48%-9.08M
97.27%-6.98M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -36.43%6M-37.21%27.84M-55.44%4.41M-36.46%5.81M-14.71%8.19M-39.92%9.44M-61.71%44.34M-81.33%9.89M-54.52%9.14M-43.92%9.6M
Selling and administrative expenses -26.53%4.25M-47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M-63.56%27.31M-88.33%5.43M-63.74%5.01M-46.68%6.64M
-General and administrative expense -26.53%4.25M-47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M-63.56%27.31M-88.33%5.43M-63.74%5.01M-46.68%6.64M
Research and development costs -52.11%1.75M-21.47%13.37M-43.13%2.53M-19.74%3.31M30.93%3.87M-33.43%3.65M-15.95%17.03M-30.52%4.46M-34.21%4.13M-36.51%2.96M
Other operating expenses ------250K--0------250K--------------------
Operating profit 36.43%-6M37.21%-27.84M55.44%-4.41M36.46%-5.81M14.71%-8.19M39.92%-9.44M61.71%-44.34M81.33%-9.89M54.52%-9.14M43.92%-9.6M
Net non-operating interest income expense -230.13%-203K50.20%374K-104.51%-6K-16.84%79K530.43%145K5,300.00%156K1,483.33%249K6,750.00%133K2,000.00%95K560.00%23K
Non-operating interest income -82.69%27K98.39%494K-43.08%74K25.26%119K530.43%145K--156K--249K--130K--95K--23K
Non-operating interest expense --230K--120K2,766.67%80K--40K--0--0--0-250.00%-3K--0--0
Other net income (expense) 81.42%-327K-162.03%-2.69M116.46%80K-800.00%-333K-125.97%-674K-177.88%-1.76M-80.96%4.33M-102.15%-486K99.78%-37K-84.74%2.6M
Gain on sale of security 81.42%-327K-974.80%-2.69M116.46%80K-800.00%-333K-681.03%-674K-1,221.02%-1.76M-114.78%-250K-155.93%-486K99.78%-37K-99.33%116K
Special income (charges) ------0--0--0--0-----78.24%4.58M--0--0798.31%2.48M
-Less：Restructuring and merger&acquisition ------0--0--0--0----78.12%-4.58M--0--0-798.31%-2.48M
Income before tax 40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M
Income tax
Net income 40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M
Net income continuous Operations 40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M
Minority interest income
Net income attributable to the parent company 40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M
Preferred stock dividends
Other preferred stock dividends 9K0
Net income attributable to common stockholders 40.86%-6.53M24.14%-30.16M57.61%-4.34M33.26%-6.06M-24.85%-8.72M17.91%-11.04M88.61%-39.75M66.32%-10.24M75.48%-9.08M97.27%-6.98M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg